Antibody Levels Associated With Reduced Risk of Invasive Group B Streptococcus Disease in Infants Aged Less Than 90 Days
Status
Withdrawn
Conditions
Invasive Group B Streptococcus Disease
Details and patient eligibility
About
Compare anticapsular antibody levels against Group B Streptococcus at delivery in mothers and their infants who develop disease versus those who do not. Use this comparison to establish antibody levels associated with reductions in risk of GBS disease in infants aged less than 90 days.
Sex
Female
Ages
18+ years old
Volunteers
Accepts Healthy Volunteers
Inclusion criteria
- Pregnant women attending participating community/hospital antenatal clinics and/or delivering at participating delivery centers.
- Subjects aged ≥18 years.
- Able to understand and comply with planned study procedures.
- Provides written informed consent.
Exclusion criteria
- Refuses to consent to study participation.
Trial design
0 participants in 2 patient groups
Controls
Description:
Infants born to GBS colonized mother who do not develop GBS disease
Cases
Description:
Infants with culture confirmed GBS disease
Trial contacts and locations
1
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems